Business Context and Reporting Period
This Form 8-K is filed by Landec Corporation (not Lifecore Biomedical, Inc., as indicated in the metadata request) for the reporting period of October 11, 2021. The filing reports on the separation of a senior executive and the associated compensatory arrangements.
Key Financial Metrics
The filing does not provide general financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The only financial data disclosed relates to the specific severance package for the departing executive:
- Salary Continuation: $258,633.18 (representing 39 weeks of base salary).
- Equity Acceleration: Full accelerated vesting of Restricted Stock Units (RSUs) granted on July 25, 2019.
Material Changes
The primary material change reported is the departure of Timothy P. Burgess, who served as Vice President of Landec Corporation and Senior Vice President of Supply Chain for its wholly-owned subsidiary, Curation Foods, Inc. His employment ended effective October 11, 2021.
Management Commentary, Risks, and Contingencies
Separation Terms: Mr. Burgess entered into a Separation Agreement and General Release. The payments and benefits are contingent upon him not revoking the agreement by October 20, 2021. The agreement includes a general release of claims against the Company and its affiliates.
Unusual Items: The filing notes that the description of the Separation Agreement is not complete and refers investors to Exhibit 10.1 for the full terms.
Investor Verification Checklist
- Verify the exact number of RSUs granted on July 25, 2019, to assess the total equity value of the accelerated vesting.
- Confirm whether the Separation Agreement was revoked by the October 20, 2021 deadline.
- Review the full text of Exhibit 10.1 for any additional non-compete, non-solicit, or confidentiality provisions.
- Check subsequent filings for the appointment of a replacement for the Supply Chain role at Curation Foods.